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NF-κB–inducing kinase controls
lymphocyte and osteoclast activities
in inflammatory arthritis
Kunihiko Aya,1,2 Muhammad Alhawagri,3 Amanda Hagen-Stapleton,3 Hideki Kitaura,1
Osami Kanagawa,1 and Deborah Veis Novack1,3
1Department

of Pathology and Immunology and 2Department of Pediatrics, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan.
of Bone and Mineral Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.

3Division

NF-κB is an important component of both autoimmunity and bone destruction in RA. NF-κB–inducing kinase
(NIK) is a key mediator of the alternative arm of the NF-κB pathway, which is characterized by the nuclear
translocation of RelB/p52 complexes. Mice lacking functional NIK have no peripheral lymph nodes, defective
B and T cells, and impaired receptor activator of NF-κB ligand–stimulated osteoclastogenesis. We investigated
the role of NIK in murine models of inflammatory arthritis using Nik–/– mice. The serum transfer arthritis
model is initiated by preformed antibodies and required only intact neutrophil and complement systems in
recipients. While Nik–/– mice had inflammation equivalent to that of Nik+/+ controls, they showed significantly
less periarticular osteoclastogenesis and less bone erosion. In contrast, Nik–/– mice were completely resistant
to antigen-induced arthritis (AIA), which requires intact antigen presentation and lymphocyte function but
not lymph nodes. Additionally, transfer of Nik+/+ splenocytes or T cells to Rag2–/– mice conferred susceptibility
to AIA, while transfer of Nik–/– cells did not. Nik–/– mice were also resistant to a genetic, spontaneous form of
arthritis, generated in mice expressing both the KRN T cell receptor and H-2g7. Thus, NIK is important in the
immune and bone-destructive components of inflammatory arthritis and represents a possible therapeutic
target for these diseases.
Introduction
RA is a chronic, joint-centered autoimmune disorder characterized
by inflammation and proliferation of synovium, accompanied by
erosion of underlying cartilage and bone. Although the factors initiating this disease are not fully understood, its progression can be
largely attributed to the activation of lymphocyte and osteoclast
(OC) lineages (1). Other forms of inflammatory arthritis, such as
that accompanying psoriasis, have similar pathogenesis (2, 3).
Early in the course of RA, T cells localize to the synovium, where
they interact with resident macrophage-like type A synoviocytes
(4). In established RA, T cells represent the most abundant inflammatory cell in the joint, where they stimulate type A synoviocytes
to secrete proinflammatory cytokines. In addition, T cells also
induce B cell maturation, a necessary step in the generation of
rheumatoid factors, polyclonal antibodies against the Fc domain
of IgG. Additionally, antibodies with specificity for a variety of foreign antigens, as well as autoantigens, can be found in RA synovial
tissue, where they activate the complement cascade, contributing
to joint destruction (1). However, no single autoantibody has been
found in all patients. Susceptibility to RA is also linked to particular alleles in the major histocompatibility locus, which suggests
that the context of antigen presentation to lymphocytes is also
important. Thus, both T and B lymphocyte activation contribute
to joint inflammation and injury.
Nonstandard abbreviations used: AIA, antigen-induced arthritis; IKKα, IκB
kinase α; LT-α, lymphotoxin-α; mBSA, methylated BSA: NIK, NF-κB–inducing kinase;
OC, osteoclast; PTH, parathyroid hormone; RANKL, receptor activator of NF-κB
ligand; STA, serum transfer arthritis; TRAP, tartrate resistant acid phosphatase.
Conflict of interest: The authors have declared that no conflict of interest exists.
Citation for this article: J. Clin. Invest. 115:1848–1854 (2005).
doi:10.1172/JCI23763.
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Degradation of bone, a major component of the crippling RA
lesion, can only be accomplished by OCs, which are derived from
monocytes/macrophages in the pannus (5). The critical mediators of osteoclastogenesis, M-CSF and receptor activator of NF-κB
ligand (RANKL), are expressed by bone marrow stromal cells,
osteoblast, and activated T cells. Importantly, RANKL expression
by synovial fibroblastoid cells is enhanced in RA joints (6), as are
other cytokines that enhance osteoclastogenesis, such as TNF-α.
Blockade of RANKL blocks bone erosion in models of adjuvant
arthritis (7) or serum transfer (8). Mice expressing a human TNF-α
transgene on a c-fos–/– background completely lack functional
OCs and are fully protected against bone erosion in spite of severe
inflammatory arthritis (9), which confirms the central role of OCs
in arthritic osteolysis.
Because the differentiation and function of T and B lymphyocytes and OCs is dependent on NF-κB (10, 11) and because the
inflammatory milieu induces NF-κB activation in these target cells,
inhibitors of NF-κB are considered to be of potential therapeutic
use in the treatment of RA (12). It is now recognized that there are 2
distinct NF-κB pathways, classical and alternative (13). The classical
pathway, activated by most NF-κB–inducing cytokines, including
TNF-α and IL-1, involves degradation of IκBα and release of active
NF-κB dimers, primarily p65/p50, into the nucleus. The alternative pathway, activated by a subset of cytokines including CD40L,
lymphotoxin-β (Lt-β), and RANKL, is controlled by NF-κB–inducing kinase (NIK), which activates IκB kinase α (IKKα), prompting
generation of the active NF-κB subunit p52 from its precursor
p100. The alternative pathway is activated in concert with the classical pathway by these cytokines, and its primary transcriptionally
active nuclear complex is RelB/p52. Several studies have shown that
blockade of classical NF-κB signaling, through the use of inhibitors
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Figure 1
Equivalent inflammatory response to serum transfer arthritis. Response of Nik+/+ and Nik–/– mice to arthritogenic serum was evaluated from days
0 to 14 by clinical scoring (A) and measurement of hind paw thickness (B). Clinical scores were obtained by observation of all 4 paws, with a
maximum score of 4 indicating whole-paw redness and swelling in all 4. Hind paw thickness was measured by digital gauge at the ankle, and
the sum of the data for both paws was plotted. Graphs show mean ± SEM at each data point for 8 mice. There were no significant differences
(P < 0.05) in either parameter between Nik+/+ and Nik–/– mice. (C) Semiquantitative RT-PCR analysis of RNA derived from hind paws at days 0,
3, and 4 shows that RANKL and TNF-α are both induced by injection of arthritogenic serum in Nik+/+ and Nik–/– animals.

and in knockout mice, reduces both inflammation and bone erosion in murine models of arthritis (14–17). However, because of its
central role in many normal biological processes, global inhibition
of classical NF-κB may not be therapeutically viable. The alternative
NF-κB pathway appears to be activated by a much more restricted
set of signals and thus might represent a better therapeutic target.
However, none of the previous studies addresses the possible role
of this pathway in arthritis.
The role of the NIK/IKKα/p100/p52 pathway in the immune
system has been established in several model systems. NIK-deficient mice lack peripheral lymph nodes and Peyer’s patches, due
to defects in the stromal cell response to Lt-β (18–20). In intact
NIK-deficient animals, this stromal cell abnormality also contributes to lymphocyte dysfunction, with decreased antibody production after immunization (18) and delayed clearance of pathogens
(21, 22). Bone marrow transplant experiments have demonstrated
cell-autonomous defects in lymphocytes, including decreased
proliferation of both B and T cells and reduced antibody production, although the degree of dysfunction depends on the mode of
stimulation and the specific function assayed (23). Studies using
lymphocytes with defects in the molecules downstream of NIK
have confirmed the important role of this pathway in B cell maturation (24, 25). The reduced ability of NIK-deficient mice to clear
pathogens suggests that NIK is also important in T cell function.
However, the cell-autonomous effect of NIK deficiency in T cells
has not been explored in disease models.
We have previously shown that Nik–/– mice have normal basal
bone structure but are resistant to RANKL- or parathyroid hormone–stimulated (PTH-stimulated) osteoclastogenesis (26).
Additionally, Nik–/– precursors are highly resistant to RANKLinduced osteoclastogenesis in vitro. Although RANKL-naive
precursors have intact classical NF-κB signaling, treatment with
RANKL induces accumulation of the IκB-like p100 protein, which
leads to inhibition of both the classical and alternative pathways.
Recently it has been shown that IKKα–/– mice have a similar OC
defect (27). In contrast, Nfkb1–/–Nfkb2–/– mice, which lack both
the p50 and p52 NF-κB subunits, are osteopetrotic and have no
OCs, presumably due to an earlier and more profound blockade
in global NF-κB signaling (11, 28).
In this article, we examine the importance of NIK in the periarticular bone erosion that accompanies inflammatory arthritis
using the lymphocyte-independent serum transfer model (29).

Additionally, we explore the role of NIK in the induction of
inflammatory arthritis using 2 models dependent on lymphocyte
function, antigen-induced arthritis (AIA) (30) and the spontaneous K/BxN (KRN × NOD) model (31). We find that NIK is critical
for both the induction of inflammation by lymphocytes and for
bone erosion by OCs.
Results
Role of NIK in bone erosion. Having previously shown that Nik–/– mice
are resistant to induction of osteoclastogenesis by RANKL and
PTH in vivo (26), we set out to determine whether this would hold
true in a model of human disease such as RA. We chose a variant
of the well-described serum transfer model in which serum from
K/BxN mice is injected into naive recipients. K/BxN mice experience a spontaneous autoimmune arthritis mediated by T cell
and B cell interactions resulting in the production of pathogenic
anti–glucose-6-phosphate isomerase antibodies (32). Transfer
of serum, which contains antibodies and TNF-α, from arthritic
K/BxN mice results in the rapid development in recipients of joint
inflammation resembling the spontaneous K/BxN arthritis both
clinically and histologically (29). However, this serum transfer
arthritis (STA) is mediated primarily by neutrophils and complement and does not require T cells and B cells in the recipient (29,
33). Thus, using STA, we could examine the role of NIK in bone
erosion separate from its role in lymphocytes. Although STA can
be induced in a wide variety of mouse strains, there is significant
variability in the intensity of inflammation only (34). Our colony
of Nik?/? mice is on the 129Sv/Ev background, which is relatively
resistant to STA, with only minimal inflammation induced in
Nik+/+ mice following a single injection of serum (data not shown).
Therefore, Nik+/+ and Nik–/– mice were injected with K/BxN serum
on days 0, 2, and 7. Additionally, LPS was administered on day 2.
The clinical score and thickness of hind paws of Nik–/– mice are
very similar to those of Nik+/+ mice through day 14, with no statistically significant differences (P < 0.05) at any time point (Figure 1,
A and B). These clinical data suggest that NIK is not important for
the inflammatory response in STA.
In the setting of inflammatory arthritis, osteoclastogenesis and
bone erosion are induced by the production of RANKL and TNF-α
by inflammatory and synovial cells. We therefore investigated
the induction of these cytokines in the ankle joints of mice in the
early phases of STA by semiquantitative RT-PCR. In both Nik+/+
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and Nik–/– mice, RANKL and TNF-α messages were substantially produced. Only very high doses of RANKL (150 ng/ml), which are
increased above baseline (Figure 1C). This finding is in agreement greater than the optimal dose for wild-type osteoclastogenesis,
with a previous study that was unable to demonstrate a role for were able to synergize with TNF-α to generate some multinucleNIK in TNF-α production in the context of human RA (35).
ated, TRAP+ cells in Nik–/– cultures. The relative resistance of Nik–/–
Histological sections of hind paws were stained with H&E and precursors to RANKL- and TNF-α–induced osteoclastogenesis is
tartrate resistant acid phosphatase (TRAP), a marker of OC dif- similar to that of IKKα–/– cells (27).
ferentiation. In control mice, not injected with serum, the talus,
Role of NIK in inflammation in AIA. Because RA in humans is an
calcaneus, and metatarsal bones have smooth surfaces and open autoimmune disease mediated by the interactions of lymphocytes
joint spaces free of cells (Figure 2, A and D). OCs are confined to and APCs, we next sought to determine whether NIK was impormarrow spaces (Figure 2G, arrowheads). In Nik+/+ mice (Figure 2, B tant in the induction of lymphocyte-dependent inflammatory
and E), joint spaces are narrowed, filled primarily with neutrophils arthritis models. AIA is induced by systemic immunization with
and synoviocytes, and bone contours are irregular, showing pan- methylated BSA (mBSA), followed by local injection of mBSA into
nus invasion as well as new bone formation.
TRAP stains showed abundant OCs on the
bone surfaces, especially in areas of pannus invasion (Figure 2H, arrows). Although
Nik–/– hind paws show a similar degree of
inflammation and narrowing of joint spaces
(Figure 2, C and F), only rare OCs are seen
on largely smooth bone surfaces (Figure 2I,
arrows). New bone formation, particularly
on the dorsal tibia and plantar calcaneus,
was similar in Nik+/+ and Nik–/– mice (Figure 2, B and C, asterisk). Slides of the more
inflamed hind paw of each animal were
scored for inflammation and bone erosion,
using an arbitrary scale (see Methods), by a
blinded observer. While there was no difference in inflammation between the 2 groups,
Nik–/– paws showed significantly less bone
erosion (Figure 2J). Additionally, the number
of TRAP+ OCs on the bone surface, as well
as adjacent to marrow spaces, was quantitated in the region shown in Figure 2, G–I.
Nik–/– paws had significantly fewer OCs in
both compartments, with 4.8-fold fewer OCs
on the surface (Figure 2K). In order to confirm this histological evidence of reduced
bone resorption, we measured TRAP5b levels in the serum prior to, and on day 14 of,
STA. While Nik+/+ mice showed a significant
increase in serum TRAP5b levels, Nik–/– mice Figure 2
did not (Figure 2L). Thus, although NIK is Histological evaluation of STA. Hind paws from control mice (A, D, and G) and from Nik+/+ (B,
not required for the inflammatory response E, and H) and Nik–/– (C, F, and I) mice with STA at day 14 were sectioned and stained with
H&E (A–F) or TRAP (G–I). In control sections (A and D), bones were closely apposed, with
in STA, it is needed for bone erosion.
Previously we showed that isolated Nik–/– smooth surfaces and no inflammatory infiltrate. The TRAP stain (G) shows scattered OCs
red) at bone/marrow interfaces (arrowheads) but none on bone surfaces. In contrast,
OC precursors are resistant to RANKL-medi- (stained
Nik+/+ paws from serum-injected mice (B and E) had an extensive inflammatory infiltrate in
ated osteoclastogenesis in vitro (26). Because
the joint spaces. In the TRAP stain (H), OCs were prominent in marrow (arrowheads) and on
TNF-α synergizes with RANKL to enhance bone surfaces (arrows), particularly where the inflammatory pannus was adjacent. In these
osteoclastogenesis in wild-type cells, and areas, the bone surface was irregular, which indicates bone erosion. Nik–/– mice with arthritis
TNF-α levels are substantially elevated in (C and F) show an inflammatory infiltrate similar to that of Nik+/+ mice. However, bone conSTA (Figure 1C and ref. 15), we examined the tours remain smooth. The TRAP stain (I) shows OCs within the marrow (arrowhead) but few
effects of TNF-α on Nik–/– osteoclastogenesis on bone surfaces, even where adjacent to pannus (arrow). Scale bar: 500 µm for A–C; 200
in vitro (Supplemental Figure 2; supplemen- µm for D–F; and 100 µm for G–I. (J) Histological sections were scored for inflammation (left)
tal material available online with this article; based on H&E stains and for bone erosion (right) based on TRAP stains according to an
arbitrary scale of 0–3. (K) TRAP-stained sections were evaluated by histomorphometry in the
doi:10.1172/JCI23763DS1). In the presence
regions shown in H–I. The mean number of OCs per mm (± SD) present on the bone surface
of NIK, addition of TNFα with very low lev- (left) and at the marrow interface (right) is shown. (*P < 0.01; **P < 0.00005, Nik–/– compared
els of RANKL (2.5 ng/ml) yielded confluent with Nik+/+; n = 7–8 per group). (L) Serum levels of TRAP5b, a form of the enzyme specific
sheets of TRAP+ OCs. In the absence of NIK, for active OCs, were determined 1 day prior to first serum injection (pre) and at day 14 (STA).
only a few mononuclear TRAP+ cells were *P < 0.01 compared with pre-injection Nik+/+ by paired Student’s t test; n = 4)
1850
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Table 1
Incidence of arthritis in AIA model
Group
Nik+/–
Nik –/–
Lt-α–/–
Nik+/+→Rag2 –/–
Nik –/–→Rag2 –/–
Nik+/+ (B cells) +
Nik –/– (T cells) → Rag2 –/–
Nik –/– (B cells) +
Nik+/+ (T cells) → Rag2 –/–
Rag2 –/–

None

Mild

Severe

0
8
0
2
7
5

1
1
1
1
1
0

6
0
3
9
0
0

1

0

3

2

0

0

Data indicate the number of mice with a given condition. Arthritis was
evaluated histologically on H&E-stained sections. The difference
between Nik+/– and Nik –/– mice and between the Rag2–/– transfer groups
was significant (P < 0.001). Nik+/+→Rag2–/–, Rag2–/– mice injected with
Nik+/+ splenocytes; Nik–/–→Rag2–/–, Rag2–/– mice injected with Nik –/–
splenocytes; Nik+/+ (B cells) + Nik –/– (T cells) → Rag2–/–, Rag2–/– mice
injected with a mixture of Nik+/+ B cells and Nik –/– T cells; Nik–/– (B cells)
+ Nik+/+ (T cells) → Rag2–/–, Rag2–/– mice injected with a mixture of
Nik –/– B cells and Nik+/+ T cells.

a single joint space. Induction of AIA is dependent on T lymphocyte function (30), and, in contrast to collagen-induced arthritis,
it can be induced in a variety of mouse strains.
Nik+/– (n = 7) and Nik–/– (n = 9) mice were immunized with mBSA
and with adjuvant and pertussis toxin on days 0 and 7 and were
injected with mBSA directly into the right knee joint space on day
21. As a control, left knees were injected with PBS only. All but 1
Nik+/– mouse had severe arthritis on day 32, while none of the Nik–/–
mice showed severe inflammation (Table 1 and Figure 3, A–C). This
indicates that NIK is essential for the induction of AIA.
NIK is required for the development of lymph node stromal cells,
and in its absence there are no peripheral lymph nodes. To determine
whether lymph nodes, as a site of antigen presentation, are needed
for the induction of AIA, we studied the lymphotoxin α–/– (LT-α–/–)
mouse. LT-α–/– mice also lack peripheral lymph nodes, but their lymphocyte function is intact (36, 37). With the same induction protocol used for Nik+/– and Nik–/– mice, 3 of 4 LT-α–/– mice had severe
AIA, while the fourth had mild arthritis (Table 1 and Figure 3D).
Therefore, the presence of lymph nodes is not required for AIA.
Next, to determine whether Nik–/– lymphocytes could mediate
AIA in the presence of an intact lymph node stroma, we utilized
the AIA model in the context of lymphocyte transfer. Rag2–/– mice
have no mature T or B lymphocytes but an intact lymph node

stroma, and they are available on the same 129Sv/Ev strain as the
NIK mice. Therefore, wild-type lymphocytes do not cause a graftversus-host reaction in a nonirradiated Rag2–/– recipient (38). One
day prior to the first mBSA immunization, at day 1, we injected a
suspension of either Nik+/+ or Nik–/– splenocytes into each Rag2–/–
recipient without previous irradiation. The subsequent regimen
for induction of AIA was the same as before. Nine of 12 Rag2–/–
recipients of Nik+/+ splenocytes showed severe knee joint inflammation on day 32, compared with 0 of 8 recipients of Nik–/– cells
(P < 0.0001; Table 1 and Figure 3, E and F). To ensure that Nik–/–
lymphocytes had survived for the duration of the experiment as
well as Nik+/+ cells, we performed flow cytometry for the T cell
markers CD90 on splenocytes at the time of sacrifice (day 32). The
number of T cells was comparable in both groups (Supplemental
Figure 1). Thus, the difference in arthritis in Nik+/+ and Nik–/– recipients is not due to poor migration or survival of Nik–/– cells.
We next sought to determine whether NIK deficiency in T and/
or B lymphocytes was responsible for the observed resistance to
AIA. Therefore, we used high-speed flow sorting (MoFlo) to obtain
pure (>99% by post-sorting analysis; data not shown) populations
of B and T lymphocytes from both Nik+/+ and Nik–/– spleens, with
B220 and CD90, respectively, as markers. We then mixed Nik+/+
B cells with Nik–/– T cells (5 × 106 of each) or Nik–/– B cells with
Nik+/+ T cells, prior to injection into Rag2–/– recipients. AIA was
induced as before. While 0 of 5 recipients of Nik–/– T cells (mixed
with Nik+/+ B cells) showed histological evidence of arthritis, 3 of
4 of the recipients of Nik+/+ T cells (mixed with Nik–/– B cells) had

Figure 3
Histological evaluation of AIA. (A) PBS-injected control joint, with a relatively acellular joint space (between arrows). (B) mBSA-injected Nik+/–
knee joint showing a severe inflammatory infiltrate (between arrows) that
extends beyond the joint capsule, accompanied by bone erosion (cortical thinning; arrowhead). (C) mBSA-injected Nik –/– knee joint resembling
control joint. (D) mBSA-injected Lt-α–/– joint, showing severe inflammation despite a lack of lymph nodes. (E) mBSA-injected joint from Rag2–/–
recipient of Nik+/+ unfractionated splenocytes showing severe arthritis.
(F) mBSA-injected joint from Rag2–/– recipient of Nik –/– unfractionated
splenocytes showing no arthritis. (G) mBSA-injected joint from Rag2–/–
recipient of Nik –/– T cells and Nik+/+ B cells, showing no arthritis. (H)
mBSA-injected joint from Rag2–/– recipient of Nik+/+ T cells and Nik–/– B
cells, showing severe arthritis. Magnification in all panels, ×40.
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severe arthritis (Table 1 and Figure 3, G and H). As with unfractionated splenocytes, the levels of engraftment of WT and NIKdeficient T cells were comparable, as assessed by flow cytometry
of spleen at the time of sacrifice (data not shown). Thus, NIK is
required in T lymphocytes for induction of AIA.
Role of NIK in spontaneous K/BxN arthritis. Having determined
that NIK is critical in the initiation phase of an acute, antigeninduced model of arthritis, we next assessed the role of NIK in
a genetic model of chronic arthritis, the K/BxN model. To this
end, we separately transferred the NIK-null allele onto the KRN
T cell receptor–transgenic mouse and onto the H-2g7–transgenic
mouse. KRN+/ H-2g7 mice of all NIK genotypes were followed with
paw thickness measurements from 5 weeks of age (Figure 4A). By
this time, 11 of 13 Nik+/? mice (a group including both Nik+/+ and
Nik+/– mice) had red, swollen paws, with a total 4-paw thickness
greater than 10.7 mm. Nik–/– mice (n = 7) had no clinical signs of
arthritis, and total paw thicknesses ranged from 7.5 to 9.5 mm. By
the age of 11–15 weeks, all Nik+/– mice (n = 18) had clinical signs of
arthritis and maximum paw measurements of 11.9 to 15 mm. At
the time of sacrifice at 11–15 weeks, Nik–/– mice (n = 9) showed no
clinical arthritis, and none had total paw thickness greater than
9.6 mm. Histological analysis of both front and hind paws supports the clinical findings. Nik+/? mice show extensive joint inflammation and extensive bone remodeling, with bone fusions, irregular shapes, and new bone formation (Figure 4, B and D). Only
1 of 7 Nik–/– mice examined histologically showed any evidence
of joint inflammation, with mild arthritis in a single paw. Other
Nik–/– paws were normal (Figure 4, C and E). We conclude that NIK
is required for the induction of K/BxN arthritis.
Discussion
NF-κB activation is a component of RA in patients (12), and it
is also seen in murine models of inflammatory arthritis (14, 15,
17, 39). Several of these studies have also shown that blockade of
the classical NF-κB pathway, via inhibition of the IKK complex or
with IκBα superrepressor (15–17), diminishes the inflammatory
response and accompanying bone loss. None of these treatments
is directed at the alternative NF-κB pathway, and possible effects
of these regimens on the alternative pathway were not addressed.
Additionally no study has separated an effect on inflammation
from one on bone erosion when OCs are present. In this article, we
report that NIK, the primary control point for the activation for
the alternative NF-κB pathway, is critical for both the immunemediated initiation of inflammatory arthritis and for bone erosion
in the context of a robust neutrophilic inflammatory response.
Our previous studies showed that Nik–/– mice are resistant to the
osteoclastogenic effects of both exogenous RANKL and PTH in
vivo (26). The current data derived from the STA model, demonstrating decreased osteoclastogenesis and bone resorption, extend
the pathophysiological context of NIK action to include inflammatory bone loss. Furthermore, although others have shown that
inhibition of NF-κB diminishes bone erosion in inflammatory
arthritis, all of these studies have shown concomitant reductions
in inflammation (15–17). Although in vitro studies showed direct
effects on osteoclastogenesis with these inhibitors, the in vivo
effects might have been primarily mediated via the inflammatory
component, with the effect on OCs secondary to diminution of the
inflammation. In contrast, we found that, even in the presence of
severe inflammation, bone resorption is blocked in the absence of
NIK. We have shown previously that the loss of NIK activity in the
1852

OC lineage, but not in lymphocytes, results in defective NF-κB signaling in both the classical and alternative pathways (26). Whether
this will result in a unique sensitivity of OCs, compared with other
cell types, to blockade of the NIK pathway must be tested when
pharmacological inhibitors of this pathway are developed.
Like RA, mBSA-induced AIA results from deposition of immune
complexes in the affected joints. In order for synovial inflammation and proliferation and bone erosion to occur, T cells must
respond to APCs, which leads to B cell production of antibodies
in the context of a complex array of cytokines including TNF-α,
IL-1, and IL-6 (4). Both T cell transfer experiments (30, 40) and
cell depletion experiments (41) demonstrate that CD4 + T cells
are critical for the initiation of the inflammatory response. The
complete lack of an inflammatory response in Nik–/– mice suggests an inability of NIK-deficient T cells to respond to mBSA.
This could be due to intrinsic defects in T cells or APCs or the
lack of a site for this interaction, i.e., the lack of peripheral lymph
nodes in Nik–/– mice. Therefore, we assessed the susceptibility to
AIA of Lt-α–/– mice, which lack lymph nodes but are able to mount
a high-affinity T cell–dependent antibody response (36, 42) and
found no difference from wild-type mice. Thus, the presence of
lymph nodes is not required for the induction of AIA. Nevertheless, the lack of lymph nodes in Nik–/– mice might contribute to
their failure to respond to mBSA challenge, in combination with
the lymphocyte defects (21, 23, 43). In order to evaluate the capacity of Nik–/– cells to confer susceptibility to AIA in the presence

Figure 4
Spontaneous K/BxN arthritis. Nik –/– mice and control littermates were
bred to express both the KRN T cell receptor and H-2g7 allele, a combination that leads to severe spontaneous arthritis in wild-type mice, apparent by 5 weeks. (A) Total paw thickness (sum of results for all 4 paws) in
Nik+/? and Nik –/– mice at 5 and 11 weeks of age. *P < 0.0002 compared
with Nik+/?. (B) Arthritic forepaw from Nik+/+ mouse. (C) Nonarthritic forepaw from Nik–/– mouse. (D) Arthritic hind paw from Nik+/+ mouse. (E) Nonarthritic hind paw from Nik –/– mouse. Magnification, ×40.
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of a normal lymph node stroma, we transferred unfractionated
splenocytes (containing a mixture of T cells, B cells, and APCs)
or mixtures of purified T and B cells, into syngeneic Rag2–/– hosts.
Like SCID mice (40), Rag2–/– mice were resistant to AIA (data not
shown). Transfer of Nik+/? splenocytes or purified T cells 1 day
prior to first immunization conferred full susceptibility to AIA,
while transfer of Nik–/– splenocytes or T cells had no effect, despite
equivalent engraftment of T cells in the recipient spleens. The latter is important because of reports that NIK-defective lymphocytes
show defects in homing to lymphoid organs (38). Thus, the failure
of Nik–/– mice to respond to AIA is due to T cell dysfunction. Furthermore, although other model systems have shown at least partial immune reactions in NIK-deficient mice (21–23), the complete
resistance of Nik–/– mice to this arthritis model is unique.
In contrast to the acute serum transfer form of the K/BxN
model, which can be induced on a wide variety of mouse strains,
the genetic model, which is spontaneous and chronic, has only
been evaluated in crosses of KRN transgenic mice with NOD mice
that express H-2g7. Previously, Mandik-Nayak et al. (44) showed
that K/BxN mice lacking lymph nodes due to in utero exposure
to anti–Lt-β receptor antibodies showed a delayed and reduced
intensity of arthritis, which indicates the importance of lymph
nodes in this model. However, our experiments, in which we have
bred Nik–/– mice and control littermates to express KRN and
H-2g7, represent the first report of additional genetic influences.
Our findings, based on studies using mice lacking lymph nodes
but with additional lymphocyte abnormalities, show a more complete inhibition of arthritis, supporting the previous findings and
suggesting additional contributions of the latter cell types.
The difference in the dependence of the AIA and K/BxN models on the presence of lymph nodes is interesting. Both models
depend on systemic antigen-specific T and B lymphocyte responses, although the former is to a foreign antigen, while the latter is
to a self antigen. Additionally, AIA induction was performed in
animals with a normal T cell receptor repertoire, while the K/BxN
model is dependent on the transgenic KRN T cell receptor, which
is expressed on all T cells.
In summary, our results indicate that NIK is critical for antigenmediated induction of arthritis in both AIA and K/BxN models.
Additionally, NIK controls the pathological induction of osteoclastogenesis in the context of the STA model of inflammatory arthritis.
Methods
Animals. Nik–/– mice on the 129Sv/Ev background (18) were originally provided by R.D. Schreiber (Washington University, St. Louis, Missouri, USA).
LT-α–/– and H-2g7 mice were from the Jackson Laboratory. Rag2–/– mice of
129Sv/Ev background and NOD mice were from Taconic. All mice were 8–12
weeks of age at the start of experiments for AIA and 6–9 weeks of age for
serum transfer experiments. The genotype for NIK of all mice used was confirmed by PCR analysis of genomic DNA extracted from tail biopsies. Groups
of mice designated as Nik+/? include a combination of Nik+/+ and Nik+/– mice.
No quantitative or qualitative differences in the response of Nik+/+ and Nik+/–
mice were noted. K/BxN serum pools were prepared from arthritic mice
generated by crossing KRN T cell receptor–transgenic mice with NOD mice
(29). All experimental protocols were approved by the Institutional Animal
Studies Committee at Washington University School of Medicine.
AIA. AIA in mice was established as described previously (30). Briefly, mice
were immunized on days 0 and 7 with 100 µg mBSA (Sigma-Aldrich) emulsified in 0.1 ml complete Freund’s adjuvant (BD) by intradermal injection at
the base of tail. At the same time points (i.e., on days 0 and 7) and as an addi-

tional adjuvant, 1 µg pertussis toxin (List Biological Laboratories Inc.) was
injected intraperitoneally. Arthritis was induced at day 21 by intraarticular
injection of 100 µg of mBSA in 10 µl sterile PBS into the right knee, while the
left knee was injected with sterile PBS alone. Mice were sacrificed on day 32.
Cell transfer experiments. For splenocyte transfers, cell suspensions were made
from pooled spleens, depleted of erythrocytes in red cell removal buffer (154
mM NH4Cl, 0.1 mM EDTA, 10 mM NaHCO3) for 5 minutes, and adjusted
to 3 × 108/ml in RPMI media. Splenocytes (3 × 107) were injected into the tail
vein of nonirradiated Rag2–/– mice 1 day before the mBSA immunization protocol for AIA described above was started. In this case, 100 ng pertussis toxin
was used. For experiments using mixtures of B and T lymphocytes, splenocyte
suspensions from Nik+/+ or Nik–/– mice were stained with APC-conjugated
B220 and PE-conjugated CD90 (eBioscience Inc.) and sorted using a MoFlo
high-speed flow cytometer (DakoCytomation). Post-sorting flow cytometry
showed each population to be more than 99% free of contaminating B or T
cells. Mixtures of lymphocytes (5 × 106 of each type) were injected by tail vein
into Rag2–/– recipients, and AIA was induced as for unseparated splenocytes.
Serum transfer model and arthritis scoring. Arthritis was induced by
intraperitoneal injection of 250 µl K/BxN serum at days 0, 2, and 7 and 50
µg LPS (E. coli 011:B4; Sigma-Aldrich) on day 2. A clinical index was used to
evaluate paws over time (1 point for each affected paw; 0.5 points for a paw
with only mild swelling/redness or only a few digits affected) (34). Ankle
thickness was measured by dial gauge (Mitutoyo). Both clinical index and
ankle thickness were assessed in a blinded fashion.
Histological grading of arthritis. Mice were sacrificed, and the hind paws or
whole knees were dissected and fixed in 10% buffered formalin overnight
at 4°C. Fixed tissues were decalcified for 10–14 days in 14% EDTA, dehydrated, and embedded in paraffin. Sagittal sections (5 µm) were stained
with H&E or TRAP. Histological sections for the serum transfer model
were graded blindly. Inflammation and bone erosion were scored on a scale
of 0 to 3 (0, none; 1, mild; 2, moderate; 3, severe).
Measurement of serum TRAP5b activity. Immediately prior to sacrifice, mice
were anesthetized and bled retro-orbitally. After clotting and centrifugation, serum was collected at stored at –80°C prior to analysis using the
MouseTRAP assay (IDS Inc.) according to the manufacturer’s instructions.
Samples were tested in duplicate and results compared to the standard
curve, and mean values expressed as U/l were plotted.
FACS analysis. The spleen cells from transplanted or nontransplanted
Rag2–/– mice on day 32 were sieved to create single-cell suspensions and
washed in RPMI media. Erythrocytes were removed from spleen cell suspensions using red cell removal buffer. Cells (1 × 106) were stained with
FITC-conjugated antibody to CD90 (eBioscience Inc.) and analyzed by
flow cytometry on a FACScan using CellQuest software (BD).
RNA extraction and semiquantitative RT-PCR. Hind paw ankle joints were isolated from control mice and those at days 3 and 4 of STA, then flash frozen
in liquid nitrogen and pulverized using a CertiPrep Freezer/Mill 6750 (SPEX
CertiPrep) under liquid nitrogen to achieve a fine powder of approximately 2 × 1 × 1 mm. RNA was prepared by extracting the powder with Trizol
(Invitrogen Corp.), followed by purification with RNeasy (QIAGEN). For
each data point, tissue from 3 animals was pooled. Generation of cDNA and
PCR were performed as described previously (26), and the same primers were
used for GAPDH. Oligonucleotide primer sequences were: RANKL: sense,
5′-CGTGCAGAAGGAACTGCAACACAT-3′ and antisense, 5′-TGACTTTATGGGAACCCGATGGGA-3′; and TNF-α: sense, 5′-AATGGCCTCCCTCTCATCAGTTCT-3′ and antisense, 5′-TGAGATAGCAAATCGGCTGACGGT-3′.
All reactions were performed at the same time, with the same amount of
cDNA, using 24 cycles for GAPDH and 34 cycles for RANKL and TNF-α.
OC culture. OCs were cultured from isolated bone marrow–derived
macrophages as described previously (26), using recombinant GST-RANKL–
and M-CSF–containing supernatant. TNF-α was from R&D Systems.
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K/BxN arthritis. Nik+/– mice were crossed with KRN T cell receptor–transgenic mice bearing 2 alleles of the transgene. All offspring were screened
by PCR of tail DNA for NIK genotype and to confirm the presence KRN.
Separately, Nik+/– mice were crossed with H-2g7–transgenic mice, which
express H-2Kb. Offspring were screened by PCR for NIK genotype and
by flow cytometry of peripheral blood for the presence of the H-2g7 allele
using anti–H-2Kb antibody (BD Biosciences). Nik+/–H-2Ag7+ mice were
intercrossed, and this second generation was screened for NIK genotype
by PCR and for H-2Kb levels by flow cytometry. Nik+/– mice expressing the
highest levels of H-2Kb were considered possible H-2g7 homozygotes, and
this was tested by mating them to H-2g7-negative mice. If all offspring were
H-2Kb+ by flow cytometry, then these animals (Nik+/–H-2g7/g7) were used
for mating with Nik+/–KRN+ genotype mice. All offspring generated by this
strategy carried H-2g7, approximately half were KRN+, and the NIK genotypes were normally distributed. Front and hind paw thicknesses of KRN+
mice were measured at the ankles by digital gauge.
Statistical analysis. Data are shown as mean ± SD. Group mean values
were compared by unpaired Student’s t test. For the serum TRAP5b experiment, in which levels were tested before and after induction of arthritis, the
paired Student’s t test was used.
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